Gotham Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Gotham Therapeutics?

Gotham Therapeutics has 3 investors including Versant Ventures And Forbion Capital Partners.

Q: How much funding has Gotham Therapeutics raised to date?

Gotham Therapeutics has raised obfuscated.

Overview

Gotham Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Gotham Therapeutics

CB Rank

178989

Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.

Acquired by

858 Therapeutics

Founded

obfuscation

Private

Series A

New York, New York, United States

1-10

www.gothamtx.com/

Biotechnology

Life Science

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Key People

Lee Babiss: CEO
Past Role: PPD clinical research business of Thermo Fisher Scientific, Chief Scientific Officer & EVP of Global Laboratory Services, Discovery Innovation
Samie Jaffray: Founder

Details

Legal Name

Gotham Therapeutics Corp.

Operating Status

Active

Company Type

For Profit

Founders

Samie Jaffray

About the Company

Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.The company offers treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases.

Contact Email

info@gothamtx.com

Predictions & Insights

Growth Insight

See this Growth Insight

Gotham Therapeutics is

Lorem

to be growing

Top Contributing Factors

Operations Contraction

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Epitranscriptomics Drug Discovery Platform

A drug discovery platform focused on identifying novel drug classes targeting the epitranscriptomics machinery.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Gotham Therapeutics	3	obfuscated obfuscation	Versant Ventures	Series A
obfuscated obfuscation	Series A - Gotham Therapeutics	3	obfuscated obfuscation	Versant Ventures	Series A
obfuscated obfuscation	Series A - Gotham Therapeutics	3	obfuscated obfuscation	Versant Ventures	Series A
obfuscated obfuscation	Series A - Gotham Therapeutics	3	obfuscated obfuscation	Versant Ventures	Series A
obfuscated obfuscation	Series A - Gotham Therapeutics	3	obfuscated obfuscation	Versant Ventures	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Gotham Therapeutics	3	obfuscated obfuscation	Versant Ventures	Series A
obfuscated obfuscation	Series A - Gotham Therapeutics	3	obfuscated obfuscation	Versant Ventures	Series A
obfuscated obfuscation	Series A - Gotham Therapeutics	3	obfuscated obfuscation	Versant Ventures	Series A
obfuscated obfuscation	Series A - Gotham Therapeutics	3	obfuscated obfuscation	Versant Ventures	Series A
obfuscated obfuscation	Series A - Gotham Therapeutics	3	obfuscated obfuscation	Versant Ventures	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Versant Ventures	Yes	Series A - Gotham Therapeutics	—
Versant Ventures	Yes	Series A - Gotham Therapeutics	—
Versant Ventures	Yes	Series A - Gotham Therapeutics	—
Versant Ventures	Yes	Series A - Gotham Therapeutics	—
Versant Ventures	Yes	Series A - Gotham Therapeutics	—